Literature DB >> 6130082

Alprazolam in clinically anxious patients with depressed mood.

G C Aden.   

Abstract

A double-blind study compared alprazolam and placebo in 462 clinically anxious patients with accompanying depressed mood. Alprazolam was more effective than placebo as measured by the Hamilton Anxiety Rating Scale, the Self-Rating Symptom Scale, Target Symptoms, Physician's Global Impressions, and Patient's Global Impressions. Alprazolam was not significantly different from placebo in the number of patients reporting drowsiness, the most frequent side effect.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6130082

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  3 in total

Review 1.  Alprazolam for depression.

Authors:  Harm van Marwijk; Gideon Allick; Froukje Wegman; Arjan Bax; Ingrid I Riphagen
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11

Review 2.  Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.

Authors:  G W Dawson; S G Jue; R N Brogden
Journal:  Drugs       Date:  1984-02       Impact factor: 9.546

Review 3.  Brief review of published alprazolam clinical studies.

Authors:  R N Straw
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.